aTyr Pharma Inc ATYR

US Biotechnology

$0.31 ▲ +3.36% (+$0.01)

Open $0.29

Prev Close $0.30

Day Range $0.27 – $0.32

52W Range $0.28 – $1.12

Market Cap $30.18M

Beta 0.97

EPS (TTM) $-0.80

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2015-05-07
Shares Out.	98,050,000
Website	atyrpharma.com/ ↗
Phone	13026587581
Employees	58
Revenue	$0
Gross Profit	$0
Net Income	-$10.3M
Free Cash Flow	-$54.8M
Total Assets	$69.8M
Total Liabilities	$21.2M
Equity	$48.6M

About aTyr Pharma Inc

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

aTyr Pharma Inc is a publicly traded company under the ticker symbol ATYR on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.